LAB vs PYPL · rev $174.4M vs P/E 7.9, rev $33.17B
Standard Biotools Inc (LAB) versus PayPal Holdings Inc (PYPL) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
PayPal Holdings Inc (PYPL) is a credit services company listed on NASDAQ. It is led by Alex Chriss.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported PYPL revenue for 2025-12-31 was $33.17B. Net income was $5.23B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. PYPL currently screens at market cap $37.12B and trailing P/E 7.9.
LAB currently screens at market cap $317.1M. PYPL currently screens at market cap $37.12B and trailing P/E 7.9.
Not investment advice. Open the LAB and PYPL stock pages for the full models.
Not investment advice.